Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, PET, ANW

Petnow's Non-invasive Identification App for Dogs and Cats Gets Showcased at SuperZoo 2023


The company is looking for partnerships and pilot projects using its pet biometric identification tech.

LAS VEGAS, Aug. 2, 2023 /PRNewswire/ -- Petnow Inc. announced that its facial recognition app for dogs and cats will be showcased in upcoming SuperZoo 2023. The company has developed the innovative identification technology as an animal welfare friendly identification measure for the most commonly raised pet animals, to solve the continuing issues of more than 6 million dogs and cats entering the shelters in the U.S. every year.

The Petnow app can register and verify their identity by running simple scans, and just in case one of the registered animals gets lost, the owner will be able to report the animal as lost, then those who find lost animals will be able to notify the owner through the app. It is provided for free for those animal lovers at the moment through the App Store and Google Play.

Dr. Jesse Joonho Lim, the CEO and founder of Petnow Inc. said "The team of Petnow has been cooperating with insurance providers, government departments, and other pet insurance players across the globe," and he also mentioned that, "More services will be provided through the app in cooperation with other companies."

Petnow will be exhibiting at SuperZoo 2023 that takes place at Mandalay Bay Convention Center, booth 7611 from August 16th through 18th. Since the company was appointed as an Honoree of Best of Innovation at CES 2022, Petnow's unique concept of pet biometric identification technology has been featured in numerous major media, namely BBC, CBS, Reuters, and Fox News.

*For submission of inquiries, filling out the form at the link below will be responded to within 48 to 72 hours.
https://petnow.io/en/contact-v2/

Petnow Inc.
https://petnow.io/en

SOURCE Petnow Inc.


These press releases may also interest you

at 02:00
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, announces the successful completion of the first two enrollments in the AMEND TS European pilot study.  Dr. Bruno Melica and the team from Vila Nova de Gaia Hospital,...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results for the quarter ending March 31, 2024. "We are executing our strategy of building on our partnered...

at 00:01
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today debuted the Best Ambulatory Surgery Centers ratings of outpatient surgical centers....

at 00:00
Butterfly Play LLC is dedicated to enhancing the mental and emotional development of children through personalized play skill...

at 00:00
Amygdala Neurosciences (a private company) announced today that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company's IND-stage activities for ANS-858....

at 00:00
Pvolve, the fitness franchise that pairs low-impact, functional movement with resistance equipment to build strong, mobile bodies, is heading to San Francisco, following the franchise's latest development deal for two new studios in the Bay Area with...



News published on and distributed by: